MGIM
AXNX

M&G Investment Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

M&G Investment Management’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-40,094
Closed -$2.53M – 482
2022
Q4 		$2.53M Buy
40,094
+18,355
+84% +$1.22M 0.01% 280
2022
Q3 		$1.52K Buy
+21,739
New +$1.5M 0.01% 263

Other funds holding AXNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

M&G Investment Management's AXNX Position: Q1 2023 in Review

M&G Investment Management sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2023, closing a stake of 40,094 shares — an estimated $2.53M sold.

M&G Investment Management first reported a position in AXNX in Q3 2022 and held it in 2 quarters. The position peaked at $2.53M in Q4 2022. 236 funds tracked by Wall St. Rank hold AXNX as of Q1 2023.

  • M&G Investment Management reported no remaining Axonics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • M&G Investment Management sold 40,094 Axonics, Inc. Common Stock shares in Q1 2023, an estimated $2.53M.
  • M&G Investment Management first reported a position in Axonics, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • M&G Investment Management's Axonics, Inc. Common Stock position peaked at $2.53M in Q4 2022.
  • 236 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2023.

Based on M&G Investment Management's 13F filing for Q1 2023, filed 11 May 2023.